ABSTRACT A major goal of my research program is to develop novel molecular imaging agents and targeted therapeutics. In particular, we are (i) developing new nanoformulations that are capable of carrying extremely high payloads of radiosensitizers and/or contrast agents; (ii) investigating new targeting strategies that maximize specificity and sensitivity; (iii) developing new bioconjugation techniques that enable the highly efficient, site-specific attachment of targeting ligands to Nanoparticles and (iv) developing a new platform to rapidly produce bispecific antibodies.
Date:April 01, 2016
Time: 12:00 PM - 01:00 PM (PT)
Location:Argyros Auditorium, Arnold and Mabel Beckman Building
Presenters:Andrew Tsourkas, Ph.D. Professor, Bioengineering University of Pennsylvania
Sponsor(s):Beckman Research Institute Seminar Series Department of Molecular Medicine